Based on two of previous reports showing the upregulation of SLC6A14 in PCa cells [34,35] and our previous report regarding the anti-tumor activity of alloferon against tumor cells through the activation of NK cells [41], we examined whether alloferon affects its direct anti-tumor activity through SLC6A14 expression on Panc-1 and AsPC-1. The gene discussed is SLC6A14; the disease is posterior cortical atrophy.